BioMarin Pharmaceutical | BMRN - 员工总数

金融业

USD

USD 8.59B

现金及等价物

USD 2.22B

USD 199.48M

USD 4.61B

USD 793.15M

USD 1.44B

USD 129.65M

USD 146.05M

3.04K

EPS每股收益

USD 0.76

股本和储备

USD 6.21B

USD 571.21M

债务利息支出

USD 14.96M

USD 22.56M

USD 1.43B

USD 11.24B

USD 105.53M

USD 636.56M

USD 129.65M

普通股股本

USD 193.27M

15.28

USD 141.2M

USD 766M

销售和管理费用

USD 258.28M

USD 1.27B

贸易债权人

USD 793.15M

应收帐款人

USD 903.91M

	员工	更改		日
Acadia Pharmaceuticals	653		56	2024-12
Agios Pharmaceuticals	486		103	2024-12
Alnylam Pharmaceuticals	2.23K		130	2024-12
Amgen	28K		1.3K	2024-12
Bayer	99.72K		1.65K	2023-12
Biogen	7.6K		35	2024-12
BioMarin Pharmaceutical	3.04K		361	2024-12
Gilead Sciences	17.6K		400	2024-12
Incyte	2.62K		93	2024-12
Insmed	1.27K		359	2024-12
Ionis Pharmaceuticals	1.07K		142	2024-12
Moderna	5.8K		200	2024-12
Neurocrine Biosciences	1.8K		400	2024-12
PTC Therapeutics	939		49	2024-12
Puma Biotechnology	185		7	2023-12
Regeneron Pharmaceuticals	13.45K		1.6K	2023-12
Roche Holding	103.61K		2.69K	2022-12
Sangamo BioSciences	405		73	2023-12
Sanofi	EUR 91.57K		3.87K	2022-12
Sarepta Therapeutics	1.37K		58	2024-12
Ultragenyx Pharmaceutical	1.29K		18	2024-12
United Therapeutics	1.3K		137	2024-12
Vertex Pharmaceuticals	6.1K		700	2024-12